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Introduction
Juvenile dermatomyositis (JDM) is the most common
among the idiopathic inflammatory myopathies that
occur during the childhood.
Objectives
To analyze the disease characteristics, treatment modal-
ities and outcome of juvenile dermatomyositis (JDM) in
Croatian children.
Methods
We reviewed medical records of all patients aged ≤
18 years at disease onset who were diagnosed with JDM
during the period 1990-2012 in the pediatric departments
of four university-affiliated tertiary care hospitals in the
three largest cities in Croatia: Zagreb, Rijeka, and Split.
Results
JDM was diagnosed in 32 patients (16 girls and 16 boys)
with mean age at the disease onset 8.8 years (boys: 7.5
years, girls: 10.2 years). Average period between disease
onset and diagnosis was 9.8 months. Major clinical signs
at the first visit were muscle weakness and/or pain
(78% patients) and heliotrope rash (65% patients). Diagno-
sis was confirmed with laboratory findings (avarage CK
values at the begining of treatment were 1571 ku/L and
avarage LDH values were 735.5 ku/L), postive EMNG
(performed in 75% patients), muscle biopsy (performed in
68% patients) and thigh muscles MR findings (performed
in 12.5% patients).
Seven patients (21.8%) had severe form of JDM with vas-
culopathy: two with acute gastrointestinal perforation and
bleeding, one with urinary tract involvement and chronical
hematuria and four with multysistem involvement - brain
oedema with hallucinations, respiratory distress syndome,
myocarditis, gastrointesinal bleeding, one of them also
with retinal cotton-wool spots and papillar oedema.
In all cases therapy included corticosteroids, in most
cases combined with methotrexate and IV imunoglobu-
lines, in cases with severe vasculopathy also combined
with cyclophosphamide and plasmaphereis. In two
patients with poor response to standard multiple drug
therapy, anti-TNF therapy (infliximab) was introduced: in
9 years old girl during acute phase of disease characterised
with emphasised vasculopathy and in 16 years boy with
prolonged, chronical course of disease characterised with
extensive, progressive calcionosis.
Three patients died (9.3%): two during the acute phase
of disease because of gastrointestinal perforation, one
during the follow up because of cardiac decompensation.
In four patients (12.5%) disease assumed chronic course
with calcinosis, despite all applied therapy.
In a girl with severe acute multysistem involvement
including retinal cotton-wool spots and papillar oedema,
early introduction of infliximab resulted in rapid, complete
resolution of eye changes and excellent, fast general
recovery. In a boy with chronical course of diasease char-
acterised with progressive, extensive calcionsis, infliximab
stopped further progression of disease.
Conclusion
Early diagnosis as well as early agressive therapy (including
anti-TNF) were the key of favourable outcomes in most
patients enrolled in our study. In this respect, to our
opinion, anti-TNF therapy should be considered as a part
of an early treatment, especially in cases with severe,
progressive forms of JDM.
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